Moderna and Intellia Therapeutics are clinical-stage biotech companies.
1 report, 0 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Intellia Therapeutics are clinical-stage biotech companies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Nothing else this week.
Related events
- Intellia Therapeutics announced it will present at a conference on September 4, 2026.
- Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.
- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Robert Langer co-founded the biotech firm Moderna.
- The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.
Coverage
Newest first; wire copies grouped- Unknown outlet